Academia.eduAcademia.edu

Outline

Narrative Equity in Genomic Screening at the Population Level

2023, The American Journal of Bioethics and the Humanities

https://doi.org/10.1080/15265161.2023.2207548

Abstract

Building upon Lisa Dive, Isabella Holmes, and Ainsley J. Newson’s (2023) conclusions in “Is it Just for a Screening Program to Give People All the Information They Want?” our Open Peer Commentary argues that a more limited scope regarding return of results in public screening programs can further support disability justice by counteracting medical science’s tendency to pathologies human variation by interpreting anomaly and diversity as disease. Drawing upon our background as disability bioethicists trained in literary studies and rhetoric explore what the stories about genomic screening results can do in the world.

References (11)

  1. Allyse, A, and M. Michie. 2021. Born well: Prenatal genetics and the future of having children. Vol. 88. Springer Nature.
  2. Boardman, F. 2020. Human genome editing and the identity politics of genetic disability. Journal of Community Genetics 11 (2):125-127 doi:10.1007/s12687-019-00437-4.
  3. Dive, L., I. Holmes, and A. J. Newson. 2023. Is it just for a screening program to give all the information they want? The American Journal of Bioethics 23 (7):34-42. doi: 10.1080/15265161.2023.2207510.
  4. Dive, L, and J. Newson.2022. Reproductive carrier screen- ing: Responding to the eugenics critique. Journal of Medical Ethics 48 (12):1060-1067. doi:10.1136/medethics- 2021-107343.
  5. Farrell, R. M., and M. A. Allyse, 2018. Key ethical issues in prenatal genetics: An overview. Obstetrics and Gynecology Clinics of North America 45 (1):127-141. doi:10.1016/j. ogc.2017.10.006.
  6. Fricker, M. 2007. Epistemic injustice: Power and the ethics of knowing. New York: Oxford University Press.
  7. Knight, A., and J. Miller. 2021. Prenatal genetic screening, epistemic justice, and reproductive autonomy. Hypatia 36 (1):1-21. doi:10.1017/hyp.2020.50.
  8. Meredith, S., S. Brackett, K. M. Diaz, K. G. Freeman, E. Huggins, H. Khan, M. W. Leach, M. Levitz, M. Michie, J. Onufer, et al. 2023. Recommendations to improve the patient experience and avoid bias when prenatal screen- ing/testing. Disability and Health Journal 16 (2):101401. doi:10.1016/j.dhjo.2022.101401.
  9. Richardson, A. and K. E. Ormond. 2018. Ethical considera- tions in prenatal testing: Gebnomic testing and medical uncertainty. Seminars in Fetal & Neonatal Medicine 23 (1):1-6. doi:10.1016/j.siny.2017.10.001.
  10. Skotko, B. G., S. P. Levine, E. A. Macklin, and R. D. Goldstein. 2016. Family perspectives about Down syn- drome. American Journal of Medical Genetics. Part A 170A (4):930-41. doi:10.1002/ajmg.a.37520.
  11. Werner-Lin, A. J. L. M., Mccoyd , and B. A. Bernhardt. 2019. Actions and uncertainty: How prenatally diagnosed variants of uncertain significance become actionable. The Hastings Center Report 49 (1):S61-S71. doi:10.1002/hast.1018. Zhang, S. 2020. The last children of Down syndrome. The Atlantic. THE AMERICAN JOURNAL OF BIOETHICS 2023, VOL. 23, NO. 7, 123-126 https://doi.org/10.1080/15265161.2023.2207520 OPEN PEER COMMENTARIES From Community-Based Carrier Programs to Opportunistic Carrier Screening: How the Objective of Carrier Screening Was Lost in Translation Anne-Marie Laberge a,b a Centre Hospitalier Universitaire Sainte-Justine; b Universite de Montreal I agree with Dive et al. (2023) "that generating and reporting information about genetic variants beyond the scope of the screening program usually lacks clin- ical, and perhaps personal, utility" and that "there are CONTACT Anne-Marie Laberge anne-marie.laberge.med@ssss.gouv.qc.ca Medical Genetics, Department of Pediatrics, and Research Center, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Canada; Department of Pediatrics and Department of Preventive and Social Medicine, Universite de Montreal, Montreal, Canada.